1. Segawa K, Arisawa T, Niwa Y, et al. Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study. Am J Gastroenterol 1992;87:630–633.

2. Lee YJ, Park KS, Cho KB, et al. Shifting prevalence of gallbladder polyps in Korea. J Korean Med Sci 2014;29:1247–1252.

3. Lee KF, Wong J, Li JC, Lai PB. Polypoid lesions of the gallbladder. Am J Surg 2004;188:186–190.

4. Kwon OS, Kim YK. Are there modifiable risk factors affecting the prevalence of gallbladder polyps or those 5 mm or larger? A retrospective cross-sectional study. Medicine (Baltimore) 2021;100:e27115.

5. Myers RP, Shaffer EA, Beck PL. Gallbladder polyps: epidemiology, natural history and management. Can J Gastroenterol 2002;16:187–194.

6. Yamin Z, Xuesong B, Guibin Y, Liwei L, Fei L. Risk factors of gallbladder polyps formation in East Asian population: a meta-analysis and systematic review. Asian J Surg 2020;43:52–59.

7. Yang HL, Kong L, Hou LL, et al. Analysis of risk factors for polypoid lesions of gallbladder among health examinees. World J Gastroenterol 2012;18:3015–3019.

8. Ali TA, Abougazia AS, Alnuaimi AS, Mohammed MAM. Prevalence and risk factors of gallbladder polyps in primary health care centers among patients examined by abdominal ultrasonography in Qatar: a case-control study. Qatar Med J 2021;2021:48.

9. Lin WR, Lin DY, Tai DI, et al. Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: analysis of 34 669 cases. J Gastroenterol Hepatol 2008;23:965–969.

10. Park EJ, Lee HS, Lee SH, et al. Association between metabolic syndrome and gallbladder polyps in healthy Korean adults. J Korean Med Sci 2013;28:876–880.

11. Xu Q, Tao LY, Wu Q, et al. Prevalences of and risk factors for biliary stones and gallbladder polyps in a large Chinese population. HPB (Oxford) 2012;14:373–381.

12. Mao YS, Mai YF, Li FJ, et al. Prevalence and risk factors of gallbladder polypoid lesions in Chinese petrochemical employees. World J Gastroenterol 2013;19:4393–4399.

13. Choi YS, Do JH, Seo SW, et al. Prevalence and risk factors of gallbladder polypoid lesions in a healthy population. Yonsei Med J 2016;57:1370–1375.

14. Chen CY, Lu CL, Chang FY, Lee SD. Risk factors for gallbladder polyps in the Chinese population. Am J Gastroenterol 1997;92:2066–2068.

15. Lim SH, Kim DH, Park MJ, et al. Is metabolic syndrome one of the risk factors for gallbladder polyps found by ultrasonography during health screening? Gut Liver 2007;1:138–144.

16. Chang TS, Lo SK, Shyr HY, et al. Hepatitis C virus infection facilitates gallstone formation. J Gastroenterol Hepatol 2005;20:1416–1421.

17. Lai SW, Ng KC. Risk factors for gallstone disease in a hospital-based study. South Med J 2002;95:1419–1423.

18. Chang Y, Ryu S, Choi Y, et al. Metabolically Healthy obesity and development of chronic kidney disease: a cohort study. Ann Intern Med 2016;164:305–312.

19. Chang Y, Cho YK, Cho J, et al. Alcoholic and nonalcoholic fatty liver disease and liver-related mortality: a cohort study. Am J Gastroenterol 2019;114:620–629.

20. Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381–1395.

21. Wen CP, David Cheng TY, Tsai SP, et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr 2009;12:497–506.

22. Collett JA, Allan RB, Chisholm RJ, Wilson IR, Burt MJ, Chapman BA. Gallbladder polyps: prospective study. J Ultrasound Med 1998;17:207–211.

23. Hong CY, Sinn DH, Kang D, et al. Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: a nationwide cohort study. J Viral Hepat 2020;27:896–903.

24. Liu T, Song C, Zhang Y, et al. Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: a prospective cohort study. Int J Cancer 2022;150:1018–1028.

25. Tan YJ. Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol 2011;17:4853–4857.

26. Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer 2013;13:123–135.

27. Lee JK, Hahn SJ, Kang HW, et al. Visceral obesity is associated with gallbladder polyps. Gut Liver 2016;10:133–139.

28. Yim SY, Kim JH. The epidemiology of hepatitis B virus infection in Korea. Korean J Intern Med 2019;34:945–953.

29. Kim BH, Park JW. Epidemiology of liver cancer in South Korea. Clin Mol Hepatol 2018;24:1–9.

30. Yoon JH, Cho SH, Kim DY, Yu SJ, Han KH. Epidemiological and clinical history of viral hepatitis in Korea. Infect Chemother 2021;53:159–165.

31. Ahn DW, Jeong JB, Kang J, et al. Fatty liver is an independent risk factor for gallbladder polyps. World J Gastroenterol 2020;26:6979–6992.

32. Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol 2014;6:860–869.

33. Kwon W, Jang JY, Lee SE, Hwang DW, Kim SW. Clinicopathologic features of polypoid lesions of the gallbladder and risk factors of gallbladder cancer. J Korean Med Sci 2009;24:481–487.

34. Yu Z, Yang C, Bai X, et al. Risk factors for cholesterol polyp formation in the gallbladder are closely related to lipid metabolism. Lipids Health Dis 2021;20:26.